Several groups have identified autocrine roles for HCAR1 in the TME, where lactate produced by tumor cells activates HCAR1 and confers cancer-promoting phenotypes (14), including the upregulation of the transporters MCT1 and MCT4 and the secretion of factors that promote angiogenesis and tumor progression (15). The gene discussed is SLC16A1; the disease is neoplasm.